Skip to main content
Mahan, Amy L.

Dr. Amy L. Mahan

Counsel
  • IP Litigation
Jump To

Biography

AMY MAHAN focuses her practice on complex intellectual property matters across the life sciences, pharmaceutical, biotechnology, medical technology, and financial technology sectors. Amy has litigated extensively in key venues including the District of Delaware, Eastern District of Texas, Central and Northern Districts of California, and before the Patent Trial and Appeal Board (PTAB), and the Federal Circuit.

Amy has been recognized by Best Lawyers: Ones to Watch in America® 2026 for Litigation — Intellectual Property. In 2025, she and her team were also named “Litigators of the Week” by The American Lawyer’s Litigation Daily.

In addition to her litigation practice, Amy advises clients on transactional intellectual property matters, including the preparation, prosecution, and strategic management of international patent portfolios. She provides patent and trademark opinions related to freedom to operate, patentability, invalidity, and non-infringement, and offers guidance on the interpretation and enforcement of licensing and research collaboration agreements.

Credentials

Admissions & Certifications
  • Illinois
  • Massachusetts
Education
  • University of Pennsylvania Law School, J.D., 2017
  • Emory University, Ph.D., 2011
  • Trinity University, B.S., 2006

Capabilities

News & Insights

  • Co-author, “Amgen Hasn’t Resolved Questions on AI Medical Invention Patents,” Bloomberg Law, July 15, 2024.
  • Co-author, “Epigenetic Modulation of Homer1a Transcription Regulation in Amygdala and Hippocampus with Pavlovian Fear Conditioning,” Journal of Neuroscience, March 2012.
  • Co-author, “Fear Conditioning, Synaptic Plasticity and the Amygdala: Implications for Posttraumatic Stress Disorder,” Trends in Neuroscience, July 2011.
  • Co-author, “Post-Traumatic Stress Disorder is Associated with PACAP and the PAC1 Receptor,” Nature, February 2011.
  • Co-author, “Depression-Related Differences in Learning and Forgetting Responses to Unrelated Cues,” Acta Psychol (Amst.), March 2008.
  • Co-author, “Noradrenergic Facilitation of Shock-Probe Defensive Burying in Lateral Septum of Rats, and Modulation by Chronic Treatment with Desipramine,” Prog Neuropsychopharmacol. Biol. Psychiatry, March 2007.